Susquehanna International Group’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Sell |
115,270
-61,396
| -35% | -$805K | ﹤0.01% | 2665 |
|
|
2025
Q1 | $3.89M | Buy |
176,666
+144,953
| +457% | +$3.19M | ﹤0.01% | 1476 |
|
|
2024
Q4 | $847K | Sell |
31,713
-168,787
| -84% | -$4.51M | ﹤0.01% | 3246 |
|
|
2024
Q3 | $5.35M | Buy |
200,500
+183,724
| +1,095% | +$4.9M | ﹤0.01% | 1007 |
|
|
2024
Q2 | $302K | Sell |
16,776
-10,094
| -38% | -$182K | ﹤0.01% | 4199 |
|
|
2024
Q1 | $490K | Sell |
26,870
-27,566
| -51% | -$503K | ﹤0.01% | 3564 |
|
|
2023
Q4 | $596K | Buy |
+54,436
| New | +$596K | ﹤0.01% | 3597 |
|
|
2023
Q3 | – | Sell |
-11,735
| Closed | -$90.9K | – | 5790 |
|
|
2023
Q2 | $90.9K | Sell |
11,735
-5,150
| -31% | -$39.9K | ﹤0.01% | 5039 |
|
|
2023
Q1 | $113K | Buy |
+16,885
| New | +$113K | ﹤0.01% | 5197 |
|